Public Health Archives - Boston Life Sciences Times

instED Names Don Stiffler Chief Executive Officer

December 29, 2025

Agenus Reports Durable Responses in Refractory Ovarian Cancer With Botensilimab and Balstilimab

December 23, 2025

Quanterix Nature Study Redefines Prevalence of Alzheimer’s Disease Neuropathology in General Population

December 22, 2025

THIS WEEK'S STORIES

Establishment Labs Submits Motiva Implants to FDA for Breast Reconstruction Approval

December 29, 2025

PharmaEssentia USA Appoints Jeffrey Williams as Independent Director

December 29, 2025

Vicarious Surgical Partners With Global Software Firm to Streamline Development Operations

December 30, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Quanterix Nature Study Redefines Prevalence of Alzheimer’s Disease Neuropathology in General Population

Federal Health Leaders Join Food Allergy Fund Forum to Chart Future of Research and Innovation

Dexcom Reveals Global Diabetes Advocates for World Diabetes Day

Brighton Marine Launches $100,000 Basic-Needs Initiative to Support Boston Veterans

New Research: GLP-1 Therapies Could Reduce U.S. Mortality by 3.5% Over the Next Two Decades

Most Read

Atropos Health Taps Kevin Smith as Chief Growth Officer to Scale AI-Driven Real-World Evidence

Delcath Data Reveals HEPZATO KIT Benefits Patients Across All Subgroups

Biobeat Secures $50 Million to Replace the Blood Pressure Cuff with Wearable Patch Technology

Verastem Oncology Discontinues RAMP 203 Trial to Prioritize KRAS G12D Program

EDITOR PICKS

instED Names Don Stiffler Chief Executive Officer

Agenus Reports Durable Responses in Refractory Ovarian Cancer With Botensilimab and Balstilimab

Quanterix Nature Study Redefines Prevalence of Alzheimer’s Disease Neuropathology in General Population

THIS WEEK'S STORIES

Establishment Labs Submits Motiva Implants to FDA for Breast Reconstruction Approval

PharmaEssentia USA Appoints Jeffrey Williams as Independent Director

Vicarious Surgical Partners With Global Software Firm to Streamline Development Operations

POPULAR CATEGORY

ABOUT US

FOLLOW US